Preterm Birth Diagnostic Test Kits Market Size
Preterm Birth Diagnostic Test Kits Market size was valued at over USD 419 million in 2022 and is anticipated to grow at a CAGR of over 7.4% between 2023 and 2032. Preterm birth diagnostic test kits are medical devices or tools used to assess the risk of preterm birth in pregnant women. These tests help healthcare providers identify women that are at elevated risk of delivering their babies before 37 weeks of gestation. Additionally, the high incidence of preterm births is accelerating market growth.

Understanding the signs and symptoms of preterm labor is crucial for pregnant women, their loved ones, and healthcare professionals. By recognizing these early warning signs, prompt medical help can be sought, potentially preventing or better managing preterm birth. This awareness can spark advocacy for policies, funding, and research dedicated to improving preterm birth prevention, treatment, and long-term care. It fosters teamwork between healthcare workers, policymakers, and community groups to tackle the challenges of preterm births. This, in turn, boosts the market for diagnostic test kits for preterm birth. Furthermore, companies in this field are actively investing in research and development to create new and effective diagnostic tools for preterm birth.
Preterm Birth Diagnostic Test Kits Market Report Attributes
Report Attribute |
Details |
Base Year | 2022 |
---|
Preterm Birth Diagnostic Test Kits Market Size in 2022 | USD 420 Million |
---|
Forecast Period | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR | 7.4% |
---|
2032 Value Projection | USD 856 Million |
---|
Historical Data for | 2018 to 2022 |
---|
No. of Pages | 200 |
---|
Tables, Charts & Figures | 277 |
Segments covered | Product Type, Sample Type, End-use, and Region |
---|
Growth Drivers | - Growing incidence of preterm births
- Increasing awareness of preterm births and their complications
- Surge in number of paediatric and neonatal intensive care units
- Rising development of new and improved diagnostic test kits
|
---|
Pitfalls & Challenges | - Lack of awareness regarding these kits
- High cost of kits
|
---|
COVID-19 Impact
The COVID-19 epidemic had a moderately negative impact on the preterm birth diagnostic test kits market. The pandemic led to disruptions in healthcare systems globally, with resources and attention primarily focused on managing and responding to COVID-19. This resulted in reduced availability and access to routine preterm birth diagnostic testing. The focus of healthcare systems and researchers was largely on combating COVID-19, leading to a temporary shift in priorities away from other areas, including preterm birth diagnostics. Funding and resources were redirected towards pandemic-related efforts.
However, post pandemic to adapt to the challenges posed by the pandemic, healthcare providers have increasingly adopted telemedicine and remote testing options. Such innovations have helped bridge the gap in access to preterm birth diagnostic test kits. Therefore, COVID-19 pandemic hindered the preterm birth diagnostic test kits industry expansion.
Preterm Birth Diagnostic Test Kits Market Trends
As more babies are being born prematurely and more of these babies are surviving, there's a big need for more units to take care of them in the hospital. Premature babies need special care because they're more likely to have health problems. Thanks to all the amazing medical advances, we now have better equipment and ways to keep a close eye on these little ones. This means we can give them care that's just right for their unique needs. These advances have led to the creation of more specialized units for premature and sick babies in the hospital. And these units aren't just focused on medical care. They also recognize how important parents and family are. They encourage parents to stay close and be involved in their child's care. This makes a huge difference for families, providing support and helping them feel more connected. With all these factors coming together, there's going to be a growing demand for products that can help care for these special babies in the future.
Preterm Birth Diagnostic Test Kits Market Analysis

When it comes to preterm birth, doctors have a range of tests to help them predict which moms-to-be are at risk. These tests fall into four main categories1. Fetal fibronectin (fFN)This test checks for a protein called fFN in a mom's vaginal fluid. If fFN is present, it's a sign that the baby might be born prematurely. In 2022, this test raked in over $197 million, and it's expected to grow even bigger in the next decade, reaching over $409 million by 2032. That's because it's really good at spotting moms who are likely to have a preemie. 2. Placental alpha microglobulin-1 (PAMG-1)This test is looking for another protein, PAMG-1, which is made by the placenta. High levels of PAMG-1 can mean a higher risk of preterm birth. 3. Insulin-like growth factor binding protein-1 (IGFBP-1)This test measures the amount of IGFBP-1 in a mom's blood. Low ?????? IGFBP-1 can be a risk factor for preterm birth. 4. Other tests There are a few other tests that can help with preterm birth prediction, but they're not as common as the ones listed above. In the market for these tests, fFN has been the top dog so far, but new developments in technology are expected to shake things up in the years to come.

Preterm birth diagnostic test kits market is bifurcated based on the sample type including blood sample, urine sample, and vaginal discharge sample. The blood sample segment dominated the market and is anticipated to grow over USD 347 million by 2032. Blood-based tests have demonstrated high diagnostic accuracy in identifying biomarkers and indicators associated with preterm birth. These tests can measure specific proteins, hormones, or genetic markers present in the maternal blood that may be indicative of an increased risk of preterm birth. Thus, the aforementioned factors will drive the segmental growth.
The market for preterm birth diagnostic test kits is divided into different customer groups, like hospitals, clinics that do tests, and other places. In 2022, the clinics that do tests had the biggest share of the market, at over 43%. It's thought that by 2032, they'll make over $370 million. This group is expected to grow a lot during the time covered by the study. There are a few reasons why this group might be growing quickly. More and more tests are being done in labs, and people are choosing to use these labs because they have better technology and offer treatment at a lower cost. These clinics can also find diseases early and accurately, which helps doctors take care of their patients. This is expected to help the group grow even more in the coming years.

Market SizeThe U.S. market for preterm birth testing kits was a whopping $158 million in 2022 and is projected to soar past $344 million by 2032. Driving Forces This surge is fueled by two main factorsAffordabilityThese testing kits are becoming more accessible to expectant mothers. Technological Advances New and improved testing methods are constantly being developed. Regional GrowthNorth America, led by the U.S., is expected to dominate this market as healthcare spending continues to rise. Industry Landscape Large, established companies in the U.S. are driving innovation and product launches, providing ample choices for consumers. Regulatory Support The regulatory environment in the U.S. encourages product development and approvals, fostering further market growth in the years ahead.
Preterm Birth Diagnostic Test Kits Market Share
Some of the notable key industry players operating in the preterm birth diagnostic test kits industry include
- Abbott
- Creative Diagnostics
- Clinical Innovations
- Hologic
- IQ Products
- Qiagen
- Medixbiochemica
- Biosynex
- CooperSurgical Inc
- Sera Progonstics
- Stryker Corporation
These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development and launches to strengthen product type offerings as well as gain a competitive edge over others.
Preterm Birth Diagnostic Test Kits Market News
- In June 2021, Medix Biochemica declared the launch of ‘MedixMDx’, a new molecular diagnostic reagents division offering a vast range of products and services. Such initiatives are anticipated to bolster market growth.
Preterm birth diagnostic test kits market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Product Type
- Fetal fibronectin test kits (fFN)
- Placental alpha micro-globulin-1 test kits (PAMG-1)
- Insulin like growth factor binding protein-1 test kits (IGFBP-1)
- Others
By Sample Type
- Blood sample
- Urine sample
- Vaginal discharge sample
By End-use
- Hospitals
- Diagnostic centers
- Clinics
- Others
The above information is provided for the following regions and countries
- North America
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Poland
- Switzerland
- Norway
- Finland
- Sweden
- Denmark
- The Netherlands
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Indonesia
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Israel